by Alex Kadhim
Researchers at Bambino Gesù Children’s Hospital in Rome have reported that CD7 may be a viable CAR T-cell target in a subset of relapsed or refractory acute myeloid leukemia, and that...
by Alex Kadhim
Researchers at The Ohio State University have demonstrated that BET inhibition can reverse key immunologic and fibrotic features of bronchiolitis obliterans syndrome, a severe pulmonary form of...
by Alex Kadhim
Researchers at Nagoya University Graduate School of Medicine and collaborating hospitals in Japan have identified a peripheral blood monocyte subset that may serve as an early cellular biomarker...
by Alex Kadhim
Researchers at Memorial Sloan Kettering Cancer Center and City of Hope, together with a multicenter U.S. team and Poseida Therapeutics, have reported early clinical activity for a...
by Science Translational Medicine
Investigators designed chimeric antigen receptor (CAR) T cells to work against vascular endothelial growth factor A (VEGF), a protein that contributes to immunosuppressive tumor microenvironments...
by Blood
Scientists have identified CSF-1R blockade combined with lenalidomide maintenance therapy as a promising pathway to better progression-free survival following autologous stem cell transplantation...